Research findings differentiate prostate cancer tumors into five different types
the ONA take:
Determining the appropriate course of treatment for prostate cancer can be a challenge for clinicians.
The disease can be slow growing and never cause a problem for a man or it can be an aggressive disease requiring immediate treatment.
Scientists at Cancer Research UK recently found that prostate cancer has five distinct types, and they also found a way to determine which type of tumor a patient has.
The researchers looked for abnormal chromosomes and measured the activity of 100 genes linked to prostate cancer in healthy and cancerous tissue samples from more than 250 men. They were able to group the tumors into five different types, each with its own genetic fingerprint.
The next step is to confirm their findings in larger studies that further explore how each specific type behaves.
However, the researchers report that their findings could lead to better understanding of the disease and more effective treatment for patients who have aggressive disease.
Prostate cancer has five distinct types, with different ways to determine which type of tumor a patient has.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer
- Social Functioning Scores for Young Cancer Survivors Remain Lower Than Their Peers
- Mortality Rates Highest Among Youngest Oncology Patients, Particularly Minorities
- Survey Reveals Research Priorities for Cancer Patients, Oncology Nurses
- Smoking Increases Long-Term Risks From Radiotherapy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|